APA (7th ed.) Citation

Y, T., T, M., T, A., K, A., N, I., E, S., . . . T, T. (2023). Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results. Modern rheumatology, 33(4), 668. https://doi.org/10.1093/mr/roac084

Chicago Style (17th ed.) Citation

Y, Tanaka, et al. "Safety and Efficacy of Filgotinib for Japanese Patients with RA and Inadequate Response to MTX: FINCH 1 52-week Results and FINCH 4 48-week Results." Modern Rheumatology 33, no. 4 (2023): 668. https://doi.org/10.1093/mr/roac084.

MLA (9th ed.) Citation

Y, Tanaka, et al. "Safety and Efficacy of Filgotinib for Japanese Patients with RA and Inadequate Response to MTX: FINCH 1 52-week Results and FINCH 4 48-week Results." Modern Rheumatology, vol. 33, no. 4, 2023, p. 668, https://doi.org/10.1093/mr/roac084.